Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Healthstream (HSTM) over the last 17 years, with Q3 2025 value amounting to $7.4 million.

  • Healthstream's Capital Expenditures rose 1304.35% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.5 million, marking a year-over-year increase of 828.12%. This contributed to the annual value of $26.7 million for FY2024, which is 362.32% up from last year.
  • As of Q3 2025, Healthstream's Capital Expenditures stood at $7.4 million, which was up 1304.35% from $6.7 million recorded in Q2 2025.
  • Healthstream's Capital Expenditures' 5-year high stood at $7.8 million during Q1 2025, with a 5-year trough of $5.0 million in Q2 2021.
  • For the 5-year period, Healthstream's Capital Expenditures averaged around $6.3 million, with its median value being $6.3 million (2021).
  • In the last 5 years, Healthstream's Capital Expenditures surged by 3942.55% in 2021 and then tumbled by 1150.79% in 2022.
  • Over the past 5 years, Healthstream's Capital Expenditures (Quarter) stood at $5.4 million in 2021, then increased by 11.02% to $5.9 million in 2022, then rose by 5.25% to $6.3 million in 2023, then rose by 6.08% to $6.6 million in 2024, then rose by 11.7% to $7.4 million in 2025.
  • Its last three reported values are $7.4 million in Q3 2025, $6.7 million for Q2 2025, and $7.8 million during Q1 2025.